ADIA — Adia Nutrition, Inc.

OTC · Materials · Chemicals · CIK 1160420 ·
Last close
$0.16
Market Cap
$15.10M
52W High
$0.22
52W Low
$0.04
ADV30
13,153
Next earnings
Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 176,275 67,577 -151,920 -162,525 776,868 136,716 1,197,067
Mar 2025 71,764 14,052 -110,544 -116,219

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-86,212
Investing CF
$-8,288
Financing CF
$182,964
CapEx
$-8,288
Dividends Paid
Buybacks
EPS Diluted TTM
$0.00
As of
2026-05-21

Balance + Analyst (yfinance extras)

Retained Earnings
$-16,136,007
Inventory
$109,750
Receivables
$79,610
ST Investments
$6,450
EBIT TTM
$-262,089
Pretax Income TTM
$-278,744
Interest Exp TTM
$16,655
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$805,019
EBITDA
$-377,449
Free Cash Flow
Enterprise Value
$16,024,495
Total Cash
$136,716
Total Debt
$902,102
Shares Out
94,404,696
Trailing EPS
$0.00
Book Value
$-0.01
ROE
ROA
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 700,508 -366,492 -395,464 594,826 852,500 -179,228
Dec 2024 6,380 -174,749 -181,067 666,181 640,641 -335,476

Peers — same industry

TickerNameMarket CapLastDaily %
NAII NATURAL ALTERNATIVES INTERNATIONAL INC $15.44M $2.46
GWTI GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES $16.18M $0.04
TOMZ TOMI Environmental Solutions, Inc. $16.63M $0.72
CSDX CS DIAGNOSTICS CORP. $13.52M $0.05
CFOO China Foods Holdings Ltd. $13.45M $0.66

News headlines (Yahoo Finance, 1h cache)

Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
2026-06-10 13:15 · Yahoo
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
2026-06-08 16:51 · Yahoo
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
2026-06-02 13:30 · Yahoo
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
2026-05-26 12:00 · Yahoo
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
2026-05-20 15:58 · Yahoo
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
2026-05-15 11:59 · Yahoo
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
2026-05-11 14:04 · Yahoo
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
2026-05-05 14:08 · Yahoo
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
2026-04-28 12:30 · Yahoo
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Ye
2026-04-22 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.